Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Founded by Cary Gunn in 2007, Genalyte is backed by investors that include Verily, Khosla Ventures, HBM Healthcare Investments AG, Redmile Group, and Samsara BioCapital and is headquartered in San Diego.